Warsaw-based medical booking platform DocPlanner raises €15M Series D led by ENERN Investments
Health tech startup, DocPlanner has raised €15 million in a Series D round to further grow its SaaS healthcare booking platform. — The fresh round of funding was led by ENERN Investments …
Context & Ripple Effects
DocPlanner's €15M Series D, led by ENERN Investments, lands mid-arc for the Warsaw company: two years later it would follow up with an €80M Series E backed by One Peak Partners and Goldman Sachs Private Capital, lifting total raised to around €130M. The round also fires the starting gun on a funding race with Paris-based Doctolib, which within months closed a $42M raise of its own.
The competitive frame matters because both companies sell the same thing — SaaS booking infrastructure for medical practices — and the capital intensity of that category keeps climbing, from DocPlanner's tens of millions to Doctolib's eventual billion-euro-scale rounds.
First-order effects
- ENERN Investments takes the lead position in DocPlanner's cap table, and the fresh €15M goes directly into growing the SaaS booking platform's footprint among clinics and practitioners.
Second-order effects
- Doctolib responds on the same battlefield with progressively larger war chests — $42M in late 2017, then $170M at a $1.1B valuation — turning doctor-booking into a land-grab where clinics pick one platform and switching costs compound.
Third-order effects
- If the pattern holds, the booking layer consolidates into a few heavily capitalized incumbents while the frontier moves downstream: Berlin's Patient21 raises €100M to fuse a digital platform with physical clinics, and Poland's Infermedica adds AI triage — suggesting the appointment calendar becomes the entry point for owning more of the patient journey.
The trend: European healthcare booking platforms are escalating through ever-larger funding rounds as they compete to become the locked-in operating system for medical practices.